Conversely, S213F (found in a metastatic melanoma patient) displays a lower BAX TMD binding ability and a decrease in BCL2/ BAX mitochondrial localization (Fig. 3D), thereby providing a lower level of protection from cell death (Fig. 4C, D). This evidence concerns the gene BCL2 and metastatic melanoma.